A detailed history of Live Oak Investment Partners transactions in Amgen Inc stock. As of the latest transaction made, Live Oak Investment Partners holds 968 shares of AMGN stock, worth $300,825. This represents 0.25% of its overall portfolio holdings.

Number of Shares
968
Previous 976 0.82%
Holding current value
$300,825
Previous $262,000 6.11%
% of portfolio
0.25%
Previous 0.23%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$255.7 - $288.46 $2,045 - $2,307
-8 Reduced 0.82%
968 $278,000
Q2 2023

Jul 13, 2023

SELL
$214.27 - $253.37 $2,142 - $2,533
-10 Reduced 1.01%
976 $216,000
Q4 2022

Feb 15, 2023

BUY
$229.03 - $291.01 $225,823 - $286,935
986 New
986 $258,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $166B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Live Oak Investment Partners Portfolio

Follow Live Oak Investment Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Live Oak Investment Partners, based on Form 13F filings with the SEC.

News

Stay updated on Live Oak Investment Partners with notifications on news.